Medicina

AUG 18, 2026 · JOURNAL ARTICLE

Impact of COVID-19 Vaccination on Patients with Non-Small Cell Lung Cancer Receiving First-Line Immune Checkpoint Inhibitor Therapy: Real-World Evidence from Romania

Medicina

A real observational finding of improved survival with COVID-19 vaccination in advanced NSCLC on immunotherapy, but confounded by unmeasured factors and attenuated to borderline significance in multivariable analysis; requires prospective validation.

AUG 17, 2026 · JOURNAL ARTICLE

Beyond Weight Loss: A Comprehensive Review of Integrated Pharmacotherapy and Metabolic Bariatric Surgery in Endometrial Cancer Care

Medicina

A narrative review synthesizing evidence on metabolic interventions for endometrial cancer in obesity, offering clinical recommendations but explicitly acknowledging gaps in prospective evidence for oncologic outcomes.

AUG 17, 2026 · JOURNAL ARTICLE

Exploring the Possible Role of Endometriosis-Associated Dysbiosis in Endometrial Carcinogenesis

Medicina

This narrative review proposes a mechanistic hypothesis linking endometriosis-associated dysbiosis to endometrial carcinogenesis through multiple interconnected pathways, but acknowledges that current evidence remains limited by small heterogeneous cohorts, cross-sectional designs, and methodological variability, with dysbiosis characterized as a hypothetical rather than established causal driver.

AUG 11, 2026 · JOURNAL ARTICLE

Exosomes in Colorectal Cancer: From Tumor Biology to Diagnostic and Therapeutic Applications

Medicina

This is a narrative review synthesizing mechanistic understanding and emerging applications of exosomes in colorectal cancer; it raises questions about clinical utility rather than answering them with empirical evidence.

AUG 6, 2026 · REVIEW

Beyond Diabetes: Continuous Glucose Monitoring as a Candidate Precision Tool for Cardiovascular Prevention and Healthy Longevity—A Hypothesis-Generating Narrative Review

Medicina

This is a narrative review proposing a hypothesis-generating framework for CGM-guided prevention in healthy adults; the authors explicitly state prospective hard-endpoint trials are lacking and the approach requires rigorous outcome-based evaluation before clinical adoption.